⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL825945 | 0.88 | SMN1; SMN2 (0.33) | — | |
| SCHEMBL825888 | 0.81 | SMN1; SMN2 (0.32) | — | |
| SCHEMBL10046424 | 0.79 | TNF (0.34) | — | |
| SCHEMBL825859 | 0.79 | MEN1 (0.33) | — | |
| SCHEMBL14402218 | 0.78 | TNF (0.30) | — | |
| SCHEMBL14402350 | 0.74 | TNF (0.34) | — | |
| SCHEMBL7567498 | 0.71 | F2 (0.43) | — | |
| SCHEMBL18155542 | 0.71 | ALDH1A1 (0.36) | — | |
| SCHEMBL825848 | 0.70 | TNF (0.37) | — | |
| SCHEMBL825905 | 0.70 | SMN1; SMN2 (0.36) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2004614-B1 | TETRAHALOGENATED COMPOUNDS USEFUL AS INHIBITORS OF ANGIOGENESIS | US GOV HEALTH & HUMAN SERV (US) | 2016-10-19 | — | — | EP | disclosed |
| US-8143252-B2 | Tetrahalogenated compounds useful as inhibitors of angiogenesis | THE UNITED STATES OF AMERICA AS REPRESENTED BY THE SECRETARY OF THE DEPARTMENT OF HEALTH AND HUMAN SERVICES (US) | 2012-03-27 | — | — | US | disclosed |
| US-8143252-B2 | Tetrahalogenated compounds useful as inhibitors of angiogenesis | THE UNITED STATES OF AMERICA AS REPRESENTED BY THE SECRETARY OF THE DEPARTMENT OF HEALTH AND HUMAN SERVICES (US) | 2012-03-27 | — | — | US | disclosed |
| US-8143252-B2 | Tetrahalogenated compounds useful as inhibitors of angiogenesis | THE UNITED STATES OF AMERICA AS REPRESENTED BY THE SECRETARY OF THE DEPARTMENT OF HEALTH AND HUMAN SERVICES (US) | 2012-03-27 | — | — | US | disclosed |
| US-20090186913-A1 | Tetrahalogenated compounds useful as inhibitors of angiogenesis | THE GOVERNMENT OF THE UNITED STATES OF AMERICA DEPARTMENT OF HEALTH AND HUMAN SERVICES | 2009-07-23 | — | — | US | disclosed |
| US-20090186913-A1 | Tetrahalogenated compounds useful as inhibitors of angiogenesis | THE GOVERNMENT OF THE UNITED STATES OF AMERICA DEPARTMENT OF HEALTH AND HUMAN SERVICES | 2009-07-23 | — | — | US | disclosed |
| US-20090186913-A1 | Tetrahalogenated compounds useful as inhibitors of angiogenesis | THE GOVERNMENT OF THE UNITED STATES OF AMERICA DEPARTMENT OF HEALTH AND HUMAN SERVICES | 2009-07-23 | — | — | US | disclosed |
| EP-2004614-A1 | TETRAHALOGENATED COMPOUNDS USEFUL AS INHIBITORS OF ANGIOGENESIS | The Government of the United States of America as represented by the Secretary of the Department of Health and Human Services (US) | 2008-12-24 | — | — | EP | disclosed |
| WO-2007120669-A1 | TETRAHALOGENATED COMPOUNDS USEFUL AS INHIBITORS OF ANGIOGENESIS | THE GOVERNMENT OF THE UNITED STATES OF AMERICA AS REPRESENTED BY THE SECRETARY OF THE DEPARTMENT OF HEALTH AND HUMAN SERVICES (US) | 2007-10-25 | — | — | WO | disclosed |
| WO-2007120669-A1 | TETRAHALOGENATED COMPOUNDS USEFUL AS INHIBITORS OF ANGIOGENESIS | THE GOVERNMENT OF THE UNITED STATES OF AMERICA AS REPRESENTED BY THE SECRETARY OF THE DEPARTMENT OF HEALTH AND HUMAN SERVICES (US) | 2007-10-25 | — | — | WO | disclosed |